The in vivo antimalarial activity of methylene blue combined with pyrimethamine, chloroquine and quinine

AUTOR(ES)

Garavito, Giovanny, Bertani, Stéphane, Quiliano, Miguel, Valentin, Alexis, Aldana, Ignacio, Deharo, Eric

FONTE

Mem. Inst. Oswaldo Cruz

DATA DE PUBLICAÇÃO

2012-09

RESUMO

The effectiveness of methylene blue (MB) combined with pyrimethamine (PYR), chloroquine (CQ) or quinine (Q) was examined in a classical four-day suppressive test against a causative agent of rodent malaria, Plasmodium berghei. A marked potentiation was observed when MB was administered at a non-curative dose of 15 mg/kg/day in combination with PYR (0.19 mg/kg/day) or Q (25 mg/kg/day). No synergy was found between MB (15 mg/Kg) and CQ (0.75 mg/Kg). Our results suggest that the combination of MB with PYR or Q may improve the efficacy of these currently used antimalarial drugs.

Documentos Relacionados

• In vitro and in vivo activities of the hydroxynaphthoquinone atovaquone alone or combined with pyrimethamine, sulfadiazine, clarithromycin, or minocycline against Toxoplasma gondii.
• Chemotherapeutic Activity of Combination Doses of Chloroquine, Pyrimethamine, and Sulfamethoxy-diazine, a Long-Acting Sulfanilamide, Against Plasmodium berghei Infections in Mice
• Synergistic In Vitro Antimalarial Activity of Omeprazole and Quinine
• Regulation of heme polymerizing activity and the antimalarial action of chloroquine.
• In Vitro Activities of Pentamidine, Pyrimethamine, Trimethoprim, and Sulfonamides against Aspergillus Species